Remove en control-and-safety-assessment
article thumbnail

AbbVie Submits Regulatory Applications for SKYRIZI® (risankizumab) in Psoriatic Arthritis to FDA and EMA

The Pharma Data

1 The safety profile of SKYRIZI in these studies was generally consistent with the safety profile of SKYRIZI in plaque psoriasis, with no new safety risks observed. 3 percent; Patient’s Assessment of Pain Numerical Rating Scale (NRS) ?1.5; Patient Global Assessment-Disease Activity NRS ?2.0; HAQ-DI score ?0.5;

article thumbnail

Let's Quit Sugar With Audiobook – Let's Quit Sugar

The Pharma Data

Let's Quit Sugar With Audiobook – Let's Quit Sugar is backed with a 60 Day No Questions Asked Money Back Guarantee. Description: All You Need To Quit Sugar At One Place. Make sure your sound is turned on. Please wait up to 10 seconds for the video to load.). A new happy you or your money back! So there you have it.

Insulin 52
article thumbnail

COVID-19 Pandemic Coverage

XTalks

“Vaccine Nationalism” Could Prove the Undoing of COVID-19 Containment. Tension is mounting as nations big and small jockey around industry to ensure they are first in line to access a vaccine, should one prove to be successful against COVID-19. Novavax announced it has joined the COVID-19 vaccine team supported by “Operation Warp Speed” in July.